Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(83 sites)
United States
University of Arizona - Cancer Center, Tucson, Arizona City of Hope, Duarte, California University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles, California University of California - Irvine, Orange, California University of California (UC) Davis Comprehensive Cancer Center, Sacramento, California Stanford Cancer Center, Stanford, California Advent Health, Orlando, Florida Emory University Hospital, Atlanta, Georgia The University of Chicago Medical Center (UCMC), Chicago, Illinois Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis, Indiana Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana Ochsner Clinic Foundation, New Orleans, Louisiana Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts Barbara Ann Karmanos Cancer Institute, Detroit, Michigan Washington University in St. Louis, St Louis, Missouri New York University (NYU), New York, New York Weill Cornell Medicine, New York, New York Icahn School of Medicine at Mount Sinai, New York, New York Columbia University, New York, New York David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York University of Rochester - Wilmot Cancer Institute, Rochester, New York Montefiore Medical Center, The Bronx, New York University of North Carolina (UNC) - Chapel Hill, Chapel Hill, North Carolina University of Cincinnati Medical Center (UCMC), Cincinnati, Ohio The Ohio State University (OSU), Columbus, Ohio University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster, Pennsylvania University of Pennsylvania, Philadelphia, Pennsylvania Thomas Jefferson University, Philadelphia, Pennsylvania Allegheny General Hospital, Pittsburgh, Pennsylvania University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Carolina Urologic Research Center, Myrtle Beach, South Carolina Sarah Cannon and HCA Research Institute, Nashville, Tennessee Tennessee Oncology, Nashville, Tennessee Vanderbilt University Medical Center, Nashville, Tennessee University of Texas Southwestern, Dallas, Texas Texas Oncology, P.A, Dallas, Texas MD Anderson Cancer Center, Houston, Texas University of Utah, Salt Lake City, Utah University of Vermont Medical Center, Burlington, Vermont Inova Schar Cancer Institute, Falls Church, Virginia Australia
St Vincent's Hospital, Darlinghurst Calvary Mater Newcastle, Hunter Region, NSW GenesisCare North Shore, St Leonards Canada
Princess Margaret Hospital, Toronto British Columbia Cancer Agency, Vancouver China
Beijing Cancer hospital, Beijing Beijing Hospital, Beijing Sun Yat-Sen University- Cancer Center, Guangdong Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Tianjin Medical University Cancer Institute & Hospital, Tianjin First Affiliated Hospital of Medical College of Xian jiaotong University, Xi'an Zhejiang Provincial People's Hospital, Zhejiang France
Institut Bergonie, Bordeaux Institut Gustave Roussy, Villejuif Germany
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), München Universitaetsklinikum Tuebingen, Tübingen Israel
Rabin Medical Center, Beilinson Hospital, Petah Tikva Sheba Medical Center, Tel Litwinsky Italy
IRCCS Ospedale San Raffaele, Milan UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma Japan
National Cancer Center Hospital East, Chiba Aichi Cancer Center Hospital, Nagoya National Cancer Center Hospital, Tokyo Cancer Institute Hospital of JFCR, Tokyo Norway
Haukeland University Hospital, Bergen Oslo University Hospital, Oslo South Korea
Seoul National University Hospital, Seoul Severance Hospital, Yonsei University Health System, Seoul Asan Medical Center, Seoul Samsung Medical Center, Seoul Spain
Institut Catala d'Oncologia - L'Hospitalet, Barcelona Fundacion MD Anderson International Espana, Madrid Hospital Universitario 12 de Octubre, Madrid South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC, Madrid Hospital Universitario Marques De Valdecilla, Santander United Kingdom
The Christie NHS Foundation Trust, Manchester Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield